Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) – Equities researchers at William Blair decreased their Q3 2023 earnings per share estimates for shares of Actinium Pharmaceuticals in a report released on Tuesday, August 15th. William Blair analyst A. Hsieh now forecasts that the biotechnology company will post earnings of ($0.73) per share for the quarter, […]